---
title: "SHANDONG STEEL: General Manager Zhang Runsheng has passed away"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/246372009.md"
description: "Shandong Steel announced that Mr. Zhang Runsheng, the company's director and general manager, passed away on June 26, 2025, due to sudden illness despite rescue efforts. During his tenure as the company's director and general manager, Mr. Zhang diligently fulfilled his responsibilities and made outstanding contributions to the company's development. The company's management team is stable, and all management activities and production operations are normal"
datetime: "2025-06-27T07:38:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/246372009.md)
  - [en](https://longbridge.com/en/news/246372009.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/246372009.md)
---

# SHANDONG STEEL: General Manager Zhang Runsheng has passed away

Shandong Steel announced that Mr. Zhang Runsheng, the company's director and general manager, passed away on June 26, 2025, due to sudden illness despite rescue efforts. During his tenure as the company's director and general manager, Mr. Zhang diligently fulfilled his responsibilities and made outstanding contributions to the company's development. The company's management team is stable, and all management activities and production operations are normal

### Related Stocks

- [600022.CN](https://longbridge.com/en/quote/600022.CN.md)

## Related News & Research

- [The Strange Reason Scientists Still Need Pre-1945 Steel](https://longbridge.com/en/news/294566280.md)
- [Chongqing Iron & Steel Finalises Capital Injection into Baowu Units After Valuation Adjustments](https://longbridge.com/en/news/294550514.md)
- [Evonik-licensed 200-kiloton hydrogen peroxide plant starts production in China’s Leshan](https://longbridge.com/en/news/294320146.md)
- [Thyssenkrupp Nucera hands over skid-mounted chlor-alkali plant to Chlorum Solutions in Brazil](https://longbridge.com/en/news/294180764.md)
- [Kyoto iCAP fund makes USD 600,000 follow-on investment in Kanjin Therapeutics](https://longbridge.com/en/news/294435586.md)